CSF GAP-43 concentration correlates negatively with the Expanded Disability Status Scale (EDSS)20, and lower levels of CSF GAP-43 have been found in secondary progressive MS (SPMS) compared to early stages of MS, controls, and other neurological diseases21. The gene discussed is GAP43; the disease is myeloid sarcoma.